Developer of human gene-based therapies. The company has developed a platform to bring new disease-modifying therapies to patients with severe disorders. The company's pipeline includes gene-based therapies for lipoprotein lipase deficiency, or LPLD, Sanfilippo B, Parkinson's Disease and Hemophilia B. read more
Matthew Kapusta uniQure CEO Rating
Matthew Kapusta uniQure CEO Rating
uniQure's CEO, Matthew Kapusta, has 7 employee ratings and a score of 75/100, placing them in the Top 20% of similar size companies on Comparably with 201-500 Employees.
Where This Score Ranks uniQure's CEO Rating
- TOP20%
In the Top 20% of 2013 Similar Sized Companies on Comparably
- 1st
1st place versus 3 competitors rated on Comparably
30
Feb
83
Mar
76
Nov
B+75 / 100
Jan
uniQure CEO Matthew Kapusta Bio
Matthew Kapusta serves as the CEO / President of uniQure.
Not Enough Ratings To Show Who Ranks CEO Rating the Highest
Anonymously rate my experience at uniQureNot Enough Ratings To Show Who Ranks CEO Rating the Lowest
Anonymously rate my experience at uniQureuniQure CEO Matthew Kapusta At a Glance
The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at uniQure.
Based on 7 ratings, Matthew Kapusta ranks right above Spark Therapeutics' CEO, Jeffrey Marrazzo.
Overall, the CEO score has remained stable over the last 90 days.
uniQure CEO Matthew Kapusta Rating Trendline
- uniQure75
- Similar Size on Comparably
uniQure's CEO Rating Rank Against Similar Sized Companies on Comparably
TOP
20%
uniQure ranks in the Top 20% of other companies on Comparably with 201-500 Employees for CEO Rating Score.
Anonymously Ask uniQure Any Question
Are You an Employee at uniQure?
Anonymously Rate Your Experience & Make Work BetterSee other culture dimensions at uniQure
×